Peer Review History
| Original SubmissionSeptember 7, 2023 |
|---|
|
PONE-D-23-27897Breathing-swallowing discoordination after definitive chemoradiotherapy for head and neck cancers is associated with aspiration pneumoniaPLOS ONE Dear Dr. Yoshida, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Dec 31 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Antonino Maniaci Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We suggest you thoroughly copyedit your manuscript for language usage, spelling, and grammar. If you do not know anyone who can help you do this, you may wish to consider employing a professional scientific editing service. Whilst you may use any professional scientific editing service of your choice, PLOS has partnered with both American Journal Experts (AJE) and Editage to provide discounted services to PLOS authors. Both organizations have experience helping authors meet PLOS guidelines and can provide language editing, translation, manuscript formatting, and figure formatting to ensure your manuscript meets our submission guidelines. To take advantage of our partnership with AJE, visit the AJE website (http://learn.aje.com/plos/) for a 15% discount off AJE services. To take advantage of our partnership with Editage, visit the Editage website (www.editage.com) and enter referral code PLOSEDIT for a 15% discount off Editage services. If the PLOS editorial team finds any language issues in text that either AJE or Editage has edited, the service provider will re-edit the text for free. Upon resubmission, please provide the following: The name of the colleague or the details of the professional service that edited your manuscript A copy of your manuscript showing your changes by either highlighting them or using track changes (uploaded as a *supporting information* file) A clean copy of the edited manuscript (uploaded as the new *manuscript* file) 3. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide. Additional Editor Comments: Please perform all the revisions required. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: No ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors provided an interesting observational single center study on breathing-swallowing discoordination after definitive chemoradiotherapy for head and neck cancers. The manuscript provides original data on a novel topic. However, there are some issues that need to be addressed with a revision: - The introduction section is quite brief. Please provide additional background in order to justify the rationale and aims of the study. - Please provide the date of ethical committee approval. - Please specify the institute were the study was conducted in the methods section. - Plase use the same tamplate for all the tables. - Table 3 should be revised as for layout. - Table 4 should be unified as being a single table might increase readability. - Please remove table 5 and provide its content in the text. - The observational design of the study must be included among the limitations of the study. Reviewer #2: Introduction - Provide more background on the prevalence of dysphagia and aspiration pneumonia following chemoradiotherapy (CRT) for head and neck cancers. Cite key statistics on incidence rates. doi: 10.1002/hed.20279 and doi:10.1016/j.jvoice.2021.09.040 - Explain the pathophysiology leading to swallowing dysfunction after CRT - fibrosis, muscle weakness, sensory changes etc. - Discuss the importance of breathing-swallowing coordination in airway protection and how disorders can increase aspiration risk. - Introduce innovative techniques in H&N management like videofluoroscopy, endoscopy for swallow evaluation and esoscope to correct identificate digestive tract for correct reconstruction. Discuss and cite doi:10.3390/jcm11133639 and doi: 10.1007/s00455-022-10484-8. - Discuss prior research that has analyzed breathing-swallowing patterns in patients with dysphagia using noninvasive monitoring methods. Methods - Explain swallowing evaluation methods like Food Intake Level Scale, Hyodo score, Penetration-Aspiration Scale in more detail. - Provide more details on the swallow monitoring system - sensors used, data acquisition, analysis software etc. - Clearly define all swallowing parameters that were quantified - latency, laryngeal motion, respiratory phases etc. - Describe the food and liquid stimuli used for swallow trials along with preparation protocols. - Elaborate on participant instructions prior to swallow trials and precautions taken. - Explain the statistical tests used for comparing swallowing metrics before and after CRT. Results - When reporting changes in swallowing metrics before and after CRT, include exact p-values and effect sizes for the comparisons. - For swallowing coordination patterns, provide percentages in addition to p-values when comparing groups. - Consider including a table comparing swallowing parameters and coordination patterns before and after CRT. - Mention any differences between liquid and solid swallows in the effects of CRT on breathing-swallowing coordination. Discussion - Interpret the prolonged swallowing latency and pause duration after CRT in context of known pathophysiological effects of chemoradiation on pharyngeal muscles and sensation. - Compare the magnitude of increase in SW-I patterns to rates reported for other disorders like stroke, COPD. - Discuss possible reasons for SW-I pattern increase specifically after liquid swallows versus solids. - Compare your coordination findings to results from prior studies analyzing breathing-swallowing after chemoradiation. - Discuss whether SW-I patterns could be a predictive biomarker of aspiration risk in this population. - Suggest future studies to understand neural mechanisms underlying CRT effects on breathing-swallowing coordination. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-23-27897R1Breathing-swallowing discoordination after definitive chemoradiotherapy for head and neck cancers is associated with aspiration pneumoniaPLOS ONE Dear Dr. Yoshida, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. As you can see there are still several points that the reviewers would like to see clarified. The recommendation to include an addition figure is one that I leave to the discretion of the authors. Please submit your revised manuscript by Mar 31 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Randall J. Kimple Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) Reviewer #3: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: (No Response) Reviewer #3: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: (No Response) Reviewer #3: (No Response) ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: (No Response) Reviewer #3: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: (No Response) Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors successfully addressed all the comments provided. I believe the manuscript can be accepted in its present form. Reviewer #3: Thank you for the opportunity to review this novel work on “Breathing-Swallowing Discoordination After Definitive Chemoradiotherapy for Head and Neck Cancers is Associated with Aspiration Pneumonia”. This is an important topic given the severity and consequences of dysphagia in persons with head and neck cancer and I commend the authors for undertaking this work. I have some questions and comments about the methodology and presentation of findings that should be addressed prior to publication. Introduction • [Line 85] Authors should define abbreviations for I-SW and SW-I here as they have not been previously defined. • [Line 88] Please clarify in this sentence that the technological advances referred to, specifically the exoscope, are surgical options. • [Line 78] In this section, authors may wish to discuss prior work by Hutcheson and colleagues re: cough flow production and respiratory muscle strength in head and neck cancer patients. • Authors should highlight, at least in the introduction, that this manuscript refers to oropharyngeal dysphagia (rather than esophageal dysphagia). Methods and Materials • Patients and Methods o Please describe if inclusionary/exclusionary criteria included prior medical history or current diagnosis of dysphagia and/or respiratory disease that may increase risk for baseline respiratory-swallow discoordination. • Swallowing Evaluation o [Line 120] Please describe how the Food Intake Level Scale rating was obtained in this study (i.e., via clinical interview, chart review, etc.) o [Line 125] Please also describe how the Hyodo score and Penetration-Aspiration Scale scores were assessed and/or scored – did the participants complete an instrumental evaluation of swallowing during which the larynx was directly visualized (i.e., fiberoptic endoscopic evaluation of swallowing or a videofluoroscopic swallow study)? It is unclear from the current text whether direct visualization of the larynx was completed during this study. Given that each of these measures were validated for endoscopic examination of swallowing or videofluoroscopic swallow study analysis, use of these outcomes without direct visualization may lead to incorrect conclusions. This should be stated for transparency to the reading audience. � In addition, the authors should further clarify whether the Penetration-Aspiration Score used as part of analysis was derived as the worst score across all trials of a single consistency, the median score, or something else. o [Line 132] The authors should further expand upon the description of the Eating Assessment Tool, including what specifically was included in statistical analysis (i.e., component scores vs total score). o Were any measures associated with swallowing efficiency collected (i.e., swallowing residue)? Given that there is an increased risk for aspiration of post-swallow pharyngeal residue in this patient population, this may be important to mention. o Given the timeframe post-CRT completion, were there any measures associated with CRT that were captured (i.e., pain or discomfort)? • Monitoring of Swallowing o [Line 172] If a specific type or brand was used for the IDDSI 0 test food, please describe this in greater detail. o [Line 177] Please clarify the reason for the variability in the administered protocol for the test foods. This is currently described as “two to five times each” which appears to represent a large range of boluses administered. If the reason in variability is due to stopping criteria associated with patient safety, it would be helpful to have that described here. o If space permits, this manuscript may benefit from a diagram depicting measures that were taken at different timepoints and associated assessments for better clarification. Statistical Methods • Mean EAT-10 total scores have traditionally been used as part of pre-post analyses similar to this. Clarification regarding whether the total score was used for analysis would better assist with identifying appropriateness of the statistical methods. Results • Swallowing Evaluation o This section would benefit from further interpretation regarding the change observed following CRT. Please provide further explanation regarding findings for each of the outcome measures. o Table 2 � It appears that this table depicts “VF” as representing the Penetration-Aspiration Scale, which is scored in integer values from 1 to 8. However the range of scores in the line describing VF suggests scoring starting at 0; please clarify if these values are listed as intended. o Table 3 � Percentage symbols are missing in the Parameters column for Water and All conditions. � Punctuation is missing in several columns of this table, specific to the score ranges, such as “)” • [Line 241] Please describe how diagnosis of aspiration pneumonia was confirmed (i.e., chart review, patient report, etc.) Discussion • [Line 254, 282] Although laryngeal perception, xerostomia, etc., are known pathophysiologic effects of chemoradiation on pharyngeal muscles, these items were not reported as measured during this specific study. Based on what is included currently, the data do not appear to support the causes of the change in swallowing latency and pause duration. The authors may wish to review the phrases describing these relationships. • [Line 301] Please elaborate on limitations of this study, including its observational design and lack of a control group for comparison. If there were discrepancies between the bolus protocols across study timepoints (i.e., a difference in the total number of swallow trials), how might that effect the percentages observed in Table 3? • How do findings from this work compare/align to those of Hopkins-Rossabi and colleagues (Respiratory-swallow coordination and swallowing impairment in head and neck cancer, 2021)? ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
PONE-D-23-27897R2Breathing-swallowing discoordination after definitive chemoradiotherapy for head and neck cancers is associated with aspiration pneumoniaPLOS ONE Dear Dr. Yoshida, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by May 19 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Randall J. Kimple Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: Please address comments of the reviewer which will help to improve the quality of the manuscript. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #3: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #3: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #3: (No Response) ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #3: (No Response) ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #3: (No Response) ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #3: Thank you for the opportunity to review this article, “Breathing-Swallowing Discoordination After Definitive Chemoradiotherapy for Head and Neck Cancers is Associated with Aspiration Pneumonia”. This is an important topic given the severity and consequences of dysphagia in persons treated for head and neck cancer. I have major concerns, questions, and comments about the methodology and presentation of findings that would need to be addressed before considering publication. Some of the comments pertain to reproducibility and improving transparency in reporting based on the FRONTIERS Framework for dysphagia reporting (https://www.frontiersframework.com/app/). Methods and Materials - Swallowing evaluation: I believe elaboration on how swallowing evaluations were conducted would strengthen this manuscript since it the procedures are still unclear. - [Line 124 - 125] Videoendoscopy and Videofluoroscopy: The methods and results suggest that both a videoendoscopy and videofluoroscopy were completed by participants but it is unclear in what order these assessments were completed. Please clarify the timing of the videoendoscopic and videofluoroscopic evaluations (with respect to each other) and whether swallow monitoring was conducted concurrently. - Study Protocols: - Elaborate on the bolus administration protocols for the videoendoscopic and videofluoroscopic evaluations, especially if they are different from the swallow monitoring bolus protocol. - If barium contrast was used, provide details as to the manufacturer and viscosity. - Clarify the visualization field and positioning of participant for each of the evaluations. - For any analyses that were completed, please elaborate on any methods for blinding of studies, raters, inter/intra-rater reliability and any training that the raters may have completed prior to study analysis. - [Line 133 - 142] Hyodo score: - Please specify the equipment used for endoscopic evaluation of swallowing, whether the evaluation was recorded for later review (and any equipment used for recording). If the evaluation was recorded and analyzed, please elaborate on the timing of analysis relative to the endoscopic evaluation (i.e., real-time vs post-hoc), and what software was used for analysis. It may be beneficial to review the FRONTIERS framework sections on Videofluoroscopy or Fiberoptic Endoscopic Evaluation of Swallowing for guidance. - Clarify whether lubricant and/or anesthetic was used with any of the participants during the videoendoscopic evaluation. - [Line 143 - 149] Penetration-Aspiration Scale - Similar to the Hyodo score comments, this section would be strengthened with support of information on how the procedure was conducted and any analysis completed. - [Line 151 - 160] EAT-10 - Clarify the scoring parameters on the EAT-10 (what 0 vs 4 signify). - [Line 161] Swallowing monitoring: - Elaborate on any synchronization of the swallow evaluation procedures and any processes for aligning events. - Provide details on the bolus protocol that was planned for participants. Clarify the proportion of participants who were able to complete the full protocol vs those who could not. Statistical Analyses - If not all participants could complete the full bolus protocol for any of the swallow evaluations or swallow monitoring, how was missing data handled? Results - Patient characteristics: - Table 1: What proportion of participants may have undergone surgical intervention prior to CRT? Discussion - The majority of the discussion appears focused on respiratory-swallow coordination; the authors should consider discussion of the other measures assessed in this study (i.e., FILS, Hyodo, PAS, EAT-10) in relation to the overall findings. - [Line 314] I believe the following statement, if pertaining to the current study, may require further statistical support that I am unable to identify in the current draft of this manuscript: "In the present study, prolonged swallowing latency after CRT was attributed to edema, fibrous scarring, muscle weakness, and decreased laryngeal sensation due to chemoradiation treatment." If this statement is associated with this manuscript, detailed information regarding the relationship between edema, presence of fibrosis, muscle weakness, and laryngeal sensation should be provided. - [Line 323] The authors may wish to verify Dr. Martin-Harris's name within the discussion section - In the present study, the reported bolus protocol (line 201) is limited to two bolus viscosities of approximately the same size. What influence do the authors think having a more expansive bolus protocol may have on their findings? How does this protocol contrast to other published protocols in terms of external validity? ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 3 |
|
Breathing-swallowing discoordination after definitive chemoradiotherapy for head and neck cancers is associated with aspiration pneumonia PONE-D-23-27897R3 Dear Dr. Yoshida, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Randall J. Kimple Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #3: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #3: (No Response) ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #3: (No Response) ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #3: (No Response) ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #3: (No Response) ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #3: Thank you for addressing the previous comments. The authors may wish to address the following minor edits prior to publication: - Lines 344 - 346 and lines 402 - 404: In lines 344-346, the authors state that prolonged latency was attributed to edema, fibrous scarring, muscle weakness and decreased sensation. However, some caution should be exercised with this statement if there are no data present in this paper to support this relationship. This statement is in contrast with lines 402-404, which indicates that data on pain and discomfort (and edema, fibrosis, weakness, and sensation) were not collected. Line 367: "FOIS" is stated in this sentence - but I believe the authors intended to write "FILS". ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #3: No ********** |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .